Cargando…
C6-Ceramide Nanoliposomes Target the Warburg Effect in Chronic Lymphocytic Leukemia
Ceramide is a sphingolipid metabolite that induces cancer cell death. When C6-ceramide is encapsulated in a nanoliposome bilayer formulation, cell death is selectively induced in tumor models. However, the mechanism underlying this selectivity is unknown. As most tumors exhibit a preferential switch...
Autores principales: | Ryland, Lindsay K., Doshi, Ushma A., Shanmugavelandy, Sriram S., Fox, Todd E., Aliaga, Cesar, Broeg, Kathleen, Baab, Kendall Thomas, Young, Megan, Khan, Osman, Haakenson, Jeremy K., Jarbadan, Nancy Ruth, Liao, Jason, Wang, Hong-Gang, Feith, David J., Loughran Jr, Thomas P., Liu, Xin, Kester, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868606/ https://www.ncbi.nlm.nih.gov/pubmed/24367685 http://dx.doi.org/10.1371/journal.pone.0084648 |
Ejemplares similares
-
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia
por: Khokhlatchev, Andrei V., et al.
Publicado: (2022) -
STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemia
por: Doshi, Ushma A, et al.
Publicado: (2017) -
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma
por: Sakae, Harumi, et al.
Publicado: (2023) -
Nanoliposome C6‐Ceramide in combination with anti‐CTLA4 antibody improves anti‐tumor immunity in hepatocellular cancer
por: Qi, Xiaoqiang, et al.
Publicado: (2022) -
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice
por: Li, Guangfu, et al.
Publicado: (2018)